Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Target Group Inc. is a U.S. business entity operating within the Medicinal Chemicals & Botanical Products sector (SIC 2833). Publicly traded on the OTC under the ticker symbol CBDY, the company is incorporated in Delaware. Based on SEC EDGAR filings, CBDY reported fiscal year 2024 revenue of $6.6M, reflecting a year-over-year growth of 77.2%. Our proprietary Semantic Risk Score of 18 indicates high transparency and low reporting risk, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 2833 classification, Target Group Inc. serves as a key benchmark for investors and analysts monitoring Delaware corporate performance.
Comparison based on Standard Industrial Classification (SIC) mapping from SEC EDGAR filings.
Filing data sourced from SEC EDGAR signals. 10-K = annual report · 10-Q = quarterly · 8-K = material event.
Target Group Inc. (CBDY) — Key efficiency & solvency metrics · FY2024
Operating Margin
Sector avg: -28.31%
Net Margin
Sector avg: -50.38%
Debt-to-Equity
Sector avg: -20.14
Current Ratio
Sector avg: 2.32
| Key Metric | Company | Industry Avg | Status |
|---|---|---|---|
| Total RevenueYoY: +77.2% | $6.6M | $206.2M | ▼ Lagging |
| Net IncomeYoY: +149.6% | $161K | — | — |
| Operating MarginOperating income as % of revenue | 2.4% | -28.31% | ▲ Outperform |
| Net MarginNet income as % of revenue | 2.4% | -50.38% | ▲ Outperform |
| Debt-to-EquityTotal liabilities / stockholders equity. Lower = safer. | -2.16 | -20.14 | ▼ Leveraged |
| Current RatioCurrent assets / current liabilities. Above 1.0 = solvent. | 0.24 | 2.32 | ▼ Lagging |
Source: SEC EDGAR XBRL filings (10-K annual reports). Industry benchmarks derived from 23 companies in SIC 2833.
Disclaimer: All financial data is sourced from raw SEC EDGAR filings. Sprytne.com provides automated data visualization and algorithmic analysis for informational purposes only. This is NOT financial advice, a recommendation to buy/sell, or a guarantee of accuracy. Always verify data via official SEC sources before making investment decisions.
Federal Contracts
THE CONTRACT AWARD IS FOR THE FY21/FY22/FY23 BASE AND OPTION PRICING FOR PHASE ARRAY TRACKING RADAR TO INTERCEPT ON TARGET (PATRIOT) ADVANCED CAPABILITY-3 (PAC-3) PRODUCTION REQUIREMENTS FOR THE UNITED STATES (US) AND FOREIGN MILITARY SALES (FMS)
EXECUTE PHASED ARRAY TRACKING RADAR TO INTERCEPT ON TARGET (PATRIOT) ADVANCED CAPABILITY-3 (PAC-3) MISSILE PRODUCTION BY PROVIDING INCIDENTAL SERVICES, HARDWARE, FACILITIES, EQUIPMENT, AND TECHNICAL, PLANNING, MANAGEMENT, AND MANUFACTURING EFFORTS.
THIS ACTION IS COST PLUS INCENTIVE-FEE (CPIF) 52 MONTH ENGINEERING AND MANUFACTURING DEVELOPMENT CONTRACT, WITH THREE FIXED PRICE INCENTIVE (SUCCESSIVE TARGETS) (FPI(S)) OPTION YEARS OF LOW RATE INITIAL PRODUCTION (LRIP) FOR THE ARMORED MULTI-PURPOSE VEHICLE (AMPV) REQUIREMENT. THE AMPV FAMILY OF VEHICLES (FOV) IS A MATERIEL SOLUTION REPLACEMENT FOR THE M113 FOV TO MITIGATE CURRENT AND FUTURE CAPABILITY GAPS IN FORCE PROTECTION, MOBILITY, RELIABILITY, AND INTEROPERABILITY BY MISSION ROLE VARIANT TO SUPPORT THE ARMORED BRIGADE COMBAT TEAM (ABCT) ACROSS THE SPECTRUM OF CONFLICT. THE AMPV FOV WILL REPLACE THE FIVE MISSION ROLES CURRENTLY PERFORMED BY THE M113 FOV BY TRANSFERRING THE CURRENT M113 MISSION EQUIPMENT PACKAGES (MEP) TO A NEW VEHICLE PLATFORM. THE AMPV VEHICLE FLEET WILL CONSIST OF THE FOLLOWING FIVE VARIANTS TAILORED TO SPECIFIC MISSION ROLES WITHIN ABCT: GENERAL PURPOSE (GP) VEHICLE; MISSION COMMAND (MCMD) VEHICLE; MORTAR CARRIER (MC) VEHICLE; MEDICAL EVACUATION (ME) VEHICLE; AND MEDICAL TREATMENT (MT) VEHICLE. A TOTAL QUANTITY OF 29 VEHICLES WILL BE DELIVERED DURING EMD (INCLUDING SYSTEM SUPPORT PACKAGES, SPECIAL TOOLS AND TEST EQUIPMENT, AND BALLISTIC HULLS), WITH 52 (LRIP OPTION YEAR 1), 105 (LRIP OPTION YEAR 2), AND 130 (LRIP OPTION YEAR 3) VEHICLES ANTICIPATED DURING THE LRIP OPTION YEARS. RANGE PRICING IS INCLUDED IN THE CONTRACT FOR OPTION PERIODS 2 AND 3.
IRBM TARGETS
MRBM TARGETS
GEN III MODERNIZED TARGET ACQUISITION DESIGNATION SIGHT/PILOT NIGHT VISION SYSTEM (MTADS/PNVS), INDEFINITE DELIVERY INDEFINITE QUANTITY (IDIQ) 2
THIS CONTRACT WILL PROCURE AN ENHANCEMENT OF THE AGING AN/TPQ-36(V)8 AND AN/TPQ-37 TARGET ACQUISITION COUNTER FIRE RADAR SYSTEMS. THE CONTRACTOR WILL DELIVER TWO SYSTEMS PER MONTH IN SUPPORT OF A TOTAL OF 32 ACCELERATED INITIAL PRODUCTION (IP) SYSTEMS.
U.S. CUSTOMS AND BORDER PROTECTION (CBP) OFFICE OF INFORMATION TECHNOLOGY, (OIT) TARGETING AND ANALYSIS SYSTEMS PROGRAM DIRECTORATE (TASPD)'S OPERATIONS AND MAINTENANCE (O&M), UPGRADES, UPDATES, MODIFICATIONS AND ENHANCEMENTS CONTRACT
OTHER TARGET COST - AIRCRAFT MAINTENANCE
THIS TASK ORDER IS USED WITHIN TARGET AND COUNTERMEASURE TO SUPPORT A HARDWARE PURCHASE OF MODIFIED BALLISTIC REENTRY VEHICLE-8 (MBRV-8), ASSOCIATED OBJECTS (AO), REENTRY VEHICLE SEPARATION MODULE (RVSM) AND ELECTRICAL AND MECHANICAL SUPPORT EQUIPMENT. QUANTITY OF 8. RECURRING AND NON-RECURRING ENGINEERING IAW WITH THE SOW AND THE TARGET SYSTEM PERFORMANCE SPEC.
Source: USAspending.gov (Official Federal Award Data). Reflects prime contracts only. Last sync: 2026-03-30.
Compared to 46 peers in Medicinal Chemicals & Botanical Products (SIC 2833)
Revenue
Net Margin
SEC EDGAR XBRL filings by fiscal year
Side-by-side financial showdown — revenue, margins, and growth.
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →